GR3020312T3 - Anticoagulant combination of laci and sulfated polysaccharides - Google Patents

Anticoagulant combination of laci and sulfated polysaccharides

Info

Publication number: GR3020312T3
Authority: GR; Greece
Prior art keywords: laci; sulfated polysaccharides; combination; anticoagulant; anticoagulant combination
Prior art date: 1990-08-27

Application number

GR960401682T

Other languages

English (en)

Inventor

Tze-Chein Wun

Original Assignee

Monsanto Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-08-27

Filing date

1996-06-20

Publication date

1996-09-30

1996-06-20 Application filed by Monsanto Co filed Critical Monsanto Co

1996-09-30 Publication of GR3020312T3 publication Critical patent/GR3020312T3/el

Links

150000004676 glycans Chemical class 0.000 title abstract 2
229920001282 polysaccharide Polymers 0.000 title abstract 2
239000005017 polysaccharide Substances 0.000 title abstract 2
239000003146 anticoagulant agent Substances 0.000 title 1
229940127219 anticoagulant drug Drugs 0.000 title 1
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 abstract 1
102000004895 Lipoproteins Human genes 0.000 abstract 1
108090001030 Lipoproteins Proteins 0.000 abstract 1
230000002429 anti-coagulating effect Effects 0.000 abstract 1
230000015271 coagulation Effects 0.000 abstract 1
238000005345 coagulation Methods 0.000 abstract 1
-1 heparin Chemical class 0.000 abstract 1
229920000669 heparin Polymers 0.000 abstract 1
229960002897 heparin Drugs 0.000 abstract 1
230000005764 inhibitory process Effects 0.000 abstract 1
230000002195 synergetic effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8114—Kunitz type inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Pharmacology & Pharmacy (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Epidemiology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Zoology (AREA)
Diabetes (AREA)
Hematology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

GR960401682T 1990-08-27 1996-06-20 Anticoagulant combination of laci and sulfated polysaccharides GR3020312T3 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US57308390A	1990-08-27	1990-08-27

Publications (1)

Publication Number	Publication Date
GR3020312T3 true GR3020312T3 (en)	1996-09-30

Family

ID=24290576

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GR960401682T GR3020312T3 (en)	1990-08-27	1996-06-20	Anticoagulant combination of laci and sulfated polysaccharides

Country Status (10)

Country	Link
EP (1)	EP0473564B1 (el)
JP (1)	JPH0733336B2 (el)
AT (1)	ATE135585T1 (el)
CA (1)	CA2049873C (el)
DE (1)	DE69118056T2 (el)
DK (1)	DK0473564T3 (el)
ES (1)	ES2085462T3 (el)
GR (1)	GR3020312T3 (el)
IE (1)	IE913004A1 (el)
PT (1)	PT98779B (el)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5610148A (en) *	1991-01-18	1997-03-11	University College London	Macroscopically oriented cell adhesion protein for wound treatment
US5629287A (en) *	1991-01-18	1997-05-13	University College London	Depot formulations
US5276015A (en) *	1992-03-18	1994-01-04	Washington University	Method of inhibiting microvascular thrombosis
US6063764A (en) *	1992-06-01	2000-05-16	Washington University & Chiron Corp.	Method for using lipoprotein associated coagulation inhibitor to treat sepsis
US20030171292A1 (en)	1992-06-01	2003-09-11	Creasey Abla A.	Method for using lipoprotein associated coagulation inhibitor to treat sepsis
ITPD940054A1 (it)	1994-03-23	1995-09-23	Fidia Advanced Biopolymers Srl	Polisaccaridi solfatati
PT769962E (pt) *	1994-07-07	2003-07-31	Univ Washington	Metodo de atenuacao da estenose arterial
EP0774001B1 (en) *	1994-08-05	2002-10-16	Chiron Corporation	Production of tissue factor pathway inhibitor
US5589359A (en)	1994-08-05	1996-12-31	Chiron Corporation	Chimeric proteins
AU759412B2 (en) *	1995-06-07	2003-04-17	G.D. Searle & Co.	Method of solubilizing, purifying and refolding protein and compositions comprising proteins and solubilizing agents
EP0837883B1 (en) *	1995-06-07	2005-08-10	Chiron Corporation	Method of solubilizing, purifying, and refolding protein
AU2003200506B2 (en) *	1995-06-07	2007-01-18	G.D. Searle Llc	Method of solubilizing, purifying and refolding protein and compositions comprising proteins and solubilizing agents
US5772629A (en) *	1995-10-23	1998-06-30	Localmed, Inc.	Localized intravascular delivery of TFPI for inhibition of restenosis in recanalized blood vessels
AU1042597A (en) *	1995-12-18	1997-07-14	Stichting Sanquin Bloedvoorziening	Potentiation of complement and coagulation inhibitory properties of c1-inhibitor.
IL161407A0 (en)	2001-10-15	2004-09-27	Chiron Corp	Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (tfpi)
US7851433B2 (en)	2003-08-13	2010-12-14	Novartis Vaccines And Diagnostics, Inc.	Method of purifying TFPI and TFPI analogs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL87172A (en) *	1987-07-23	1994-12-29	Univ Washington	Method of isolating highly purified tissue factor inhibitor
IL87171A (en) *	1987-11-23	1995-08-31	Monsanto Co	cDNA of human tissue factor inhibitor
EP0439442B1 (en) *	1990-01-25	1996-03-06	Washington University	Factor x-laci hybrid protein

1991
- 1991-08-26 CA CA002049873A patent/CA2049873C/en not_active Expired - Lifetime
- 1991-08-26 AT AT91870132T patent/ATE135585T1/de not_active IP Right Cessation
- 1991-08-26 PT PT98779A patent/PT98779B/pt not_active IP Right Cessation
- 1991-08-26 JP JP3213844A patent/JPH0733336B2/ja not_active Expired - Fee Related
- 1991-08-26 ES ES91870132T patent/ES2085462T3/es not_active Expired - Lifetime
- 1991-08-26 IE IE300491A patent/IE913004A1/en not_active IP Right Cessation
- 1991-08-26 DK DK91870132.7T patent/DK0473564T3/da active
- 1991-08-26 EP EP91870132A patent/EP0473564B1/en not_active Expired - Lifetime
- 1991-08-26 DE DE69118056T patent/DE69118056T2/de not_active Expired - Lifetime
1996
- 1996-06-20 GR GR960401682T patent/GR3020312T3/el unknown

Also Published As

Publication number	Publication date
DK0473564T3 (da)	1996-04-15
EP0473564B1 (en)	1996-03-20
DE69118056D1 (de)	1996-04-25
PT98779B (pt)	1999-06-30
IE913004A1 (en)	1992-03-11
PT98779A (pt)	1992-07-31
JPH04257524A (ja)	1992-09-11
CA2049873C (en)	2001-12-04
EP0473564A1 (en)	1992-03-04
ES2085462T3 (es)	1996-06-01
JPH0733336B2 (ja)	1995-04-12
DE69118056T2 (de)	1996-10-24
CA2049873A1 (en)	1992-02-28
ATE135585T1 (de)	1996-04-15

Similar Documents

Publication	Publication Date	Title
ES2085462T3 (es)	1996-06-01	Combinacion anticoagulante de laci y de polisacaridos sulfatados.
SE9101957L (sv)	1991-12-27	Blandningar av polysackarider med laag molekylvikt samt framstaellning och anvaendning av desamma
AU5841090A (en)	1991-01-08	Sulphated polysaccharides, anticoagulant agent and anticomplementary agent obtained from brown algae fucuses and method of obtaining same
NO985978D0 (no)	1998-12-18	Insulinpreparater som inneholder karbohydrater
DE68903134D1 (de)	1992-11-12	Intraokulares vorderkammerimplantat.
BR9408585A (pt)	1997-05-06	Artigo tendo porção de cintura frontal porção de cintura posterior e porção intermediária interligando as porções de cintura frontal e posterior e artigo de fixação
JPS5795916A (en)	1982-06-15	Stabilization of vii factor activity in whole blood or blood plasma
ES2094848T3 (es)	1997-02-01	Agente de crecimiento del hepatocito.
MD306B1 (ro)	1995-10-31	Remediu pentru profilaxia afectiunilor vasculare determinate de actiunea peroxizilor glicoproteinfixati
FI921689A0 (fi)	1992-04-15	Oligosackarid med affinitet foer fibroblasttillvaextfaktor och foerfarande foer framstaellning av denna.
EP0424351A3 (en)	1991-10-09	Modified heparin cofactor ii
AU590191B2 (en)	1989-11-02	Process for the pasteurization of plasma or concentrates of blood coagulation factors II, VII, IX and X
EP0488718A3 (en)	1993-03-17	Immunostimulant agent containing interleukin-2 and 5'-deoxy-5-fluorouridine
ATE92325T1 (de)	1993-08-15	Kombinationspraeparat mit antithrombotischer wirkung.
ZA943868B (en)	1995-02-02	Novel polysaccharides having high antithrombotic and anticoagulant activity
WO2001015654A3 (fr)	2001-06-07	Polysaccharide antithrombotique de bas poids moleculaire
DK0984787T3 (da)	2003-02-03	Anvendelse af lavmolekylære hepariner til forebyggelse og behandling af hjerneødemer
AU6879091A (en)	1991-05-16	Protease nexin i/dextran sulfate anticoagulant
EP0712864A3 (en)	1996-10-16	Non-absorbable synthetic sulfated polysaccharides
ES2056997T3 (es)	1994-10-16	Copolimeros de estireno estabilizados, que contienen particulas de elastomeros.
ITMI912602A0 (it)	1991-10-01	Flangia di un subbio, particolarmente di un subbio di ordito o di catena
DK0427402T3 (da)	1993-08-16	Anvendelse af cyclodextriner og derivater deraf
Tardy-Poncet et al.	1996	ORG 10172 for heparin-induced thrombocytopenia. Tolerance and efficacity.
EP0351809A3 (en)	1991-10-30	Blood anticoagulant
GB9016609D0 (en)	1990-09-12	Compositions for the active or prophylactic treatment of intravascular coagulation or thrombosis